OrbiMed Advisors LLC's Form 4 filing
89bio, Inc. (ETNB) · filed Jan 27, 2022
- Accession no.
- 0000947871-22-000113
- Filed
- Jan 27, 2022, 5:22 PM ET
- Trade date
- Jan 25-26, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $592.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Israel GP II, L.P.CIK 0001682090 | 10% Owner |
| OrbiMed Advisors Israel II LtdCIK 0001682093 | 10% Owner |
| OrbiMed Capital GP VI LLCCIK 0001682115 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 25, 2022 | Common Stock | SSaleDisposed | −24,546 | $8.40F1 | −$206,186.4 | 1,840,175 | Indirect | |
| Jan 25, 2022 | Common Stock | SSaleDisposed | −24,545 | $8.40F1 | −$206,178 | 1,840,176 | Indirect | |
| Jan 26, 2022 | Common Stock | SSaleDisposed | −10,742 | $8.38F3 | −$90,017.96 | 1,829,433 | Indirect | |
| Jan 26, 2022 | Common Stock | SSaleDisposed | −10,740 | $8.38F3 | −$90,001.2 | 1,829,436 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average sale price of the shares of the Issuer's common stock ("Shares") sold ranging from a low of $8.40 to a high of $8.58 per Share. The Reporting Person undertakes, upon request by the Commission staff, the Issuer or a security holder of the Issuer, to provide full information regarding the number of Shares purchased at each separate price.
Referenced by the price of 2 transactions in Table I.
- F3
The Shares were sold in block sale at a price of $8.38.
Referenced by the price of 2 transactions in Table I.